X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-19 | SVRA | McCracken Joseph S | Dir | P - Purchase | $2.95 | +20,000 | 210,837 | +10% | +$59,072 | ||||||
2024-11-18 | SVRA | Ramsay David A | Dir | P - Purchase | $2.88 | +100,000 | 2,323,642 | +4% | +$287,600 | ||||||
2023-12-28 | SVRA | Pauls Matthew | CEO | S - Sale | $4.71 | -84,000 | 1,283,674 | -6% | -$395,900 | ||||||
2023-12-28 | SVRA | Lowrance David L | CFO | S - Sale | $4.71 | -10,000 | 342,355 | -3% | -$47,131 | ||||||
| D | 2023-12-28 | SVRA | Elam Nevan C | Dir | S - Sale+OE | $4.71 | -93,843 | 22,500 | -81% | -$442,291 | |||||
2023-07-17 | SVRA | Yang Rick | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Walker Paul Edward | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Sandell Scott D | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Mathers Edward T | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Makhzoumi Mohamad | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Florence Anthony A. Jr. | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Chang Carmen | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Behbahani Ali | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Baskett Forest | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-07-17 | SVRA | Growth Equity Opportunities 17, LLC | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
2023-06-26 | SVRA | Pratt Raymond Dennis | Chief Medical Officer | P - Purchase | $2.93 | +6,500 | 160,000 | +4% | +$19,045 | ||||||
| M | 2023-05-24 | SVRA | Ramsay David A | Dir | P - Purchase | $2.59 | +100,000 | 2,201,142 | +5% | +$258,529 | |||||
| M | 2022-12-29 | SVRA | Ramsay David A | Dir | P - Purchase | $1.54 | +36,000 | 2,101,142 | +2% | +$55,586 | |||||
| M | 2022-12-23 | SVRA | Ramsay David A | Dir | P - Purchase | $1.45 | +19,000 | 2,065,142 | +1% | +$27,588 | |||||
2022-12-22 | SVRA | Pratt Raymond Dennis | Chief Medical Officer | P - Purchase | $1.54 | +3,500 | 153,500 | +2% | +$5,402 | ||||||
| M | 2022-12-20 | SVRA | Ramsay David A | Dir | P - Purchase | $1.48 | +45,000 | 2,046,142 | +2% | +$66,434 | |||||
| M | 2022-12-16 | SVRA | Ramsay David A | Dir | P - Purchase | $1.50 | +54,890 | 2,001,142 | +3% | +$82,105 | |||||
| M | 2022-11-22 | SVRA | Ramsay David A | Dir | P - Purchase | $1.43 | +20,105 | 1,946,252 | +1% | +$28,652 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |